ASAlexey A. Shadrin

Alexey A. Shadrin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Alexey A. Shadrin has a total of 954 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Shared genetic architecture between premenstrual disorder symptoms and major psychiatric disorders suggests a role for calcium signaling

    by Piotr Jaholkowski, Elgeta Hysaj, Nadine Parker, Erik David Wiström, Elise M. Koch, Pravesh Parekh, Susu Qu, Srdjan Djurovic, Olav Bjerkehagen Smeland, Marit Haram, et al.

    Background: Major psychiatric disorders (MPDs) and premenstrual disorders (PMDs) are often comorbid, with indications of shared genetic architecture. However, the specific genetic variants underlying this comorbidity remain elusive. The aim of this study was to identify genomic loci shared between MPDs and PMDs, and to assess the functional characteristics of genes mapped to these loci. Methods: We used genome-wide association data for symptoms of PMDs (S-PMD, n = 67 068) from the Norwegian Mother, Father and Child Cohort Study (MoBa), and for MPDs (schizophrenia, n = 130 644; bipolar disorder, n = 827 335; major depression, n = 1 918 432) from the Psychiatric Genomic Consortium. Shared genetic loci were identified with the conjunctional false discovery rate (conjFDR). Genes mapped to the identified loci were included in functional and pharmacological gene-set enrichment analyses (GSEAs). Results: We identified 20 loci shared between S-PMD and the MPDs, including 19 novel loci for S-PMD (conjFDR<0.05). GSEA revealed genes involved in calcium signaling and neuronal projection pathways. The drug enrichment analysis identified 36 drugs, including riluzole and mianserin, significantly associated with the identified molecular pathways. Conclusions: We identified 20 genetic loci shared between the S-PMD and MPDs, implicating calcium transmission in the pathogenesis of PMDs. Together with the drug enrichment results, this provides a biological basis for repurposing existing drugs in the treatment of PMD.

  • Open Access

    Clinical trajectories and genetic architecture across the neurological–psychiatric boundary

    by J. Kopal, O.B. Smeland, E. Hagen, A. Amanzadi, B. Erdos, J. Fuhrer, A. Shadrin, O. Frei, D. van der Meer, K.S. O’COnnell, et al.

    Neurological and psychiatric disorders are treated as distinct diagnostic categories, yet genetic studies reveal substantial pleiotropy between them. Whether this overlap extends to clinical trajectories has not been tested at scale. We compared disease trajectory embeddings from Delphi-2M, a transformer model trained only on the health records of 400,000 UK Biobank participants, with genome-wide genetic correlations across 19 neurological and psychiatric disorders. Clinical and genetic similarity partly converged across disorder pairs (Mantel r = 0.33). Both measures placed most disorders closer to their own diagnostic category than to the other. Both also made the same three exceptions: multiple sclerosis, migraine, and essential tremor sat closer on average to psychiatric than to neurological disorders. Clinical trajectories and genetic architecture thus draw the same diagnostic boundary and break it in the same places. These findings support a more integrated approach to neurological and psychiatric disorders.

  • Open Access

    Early-childhood temperament deviations mark psychiatric risk into early adulthood

    by J. Kopal, N.R. Bakken, P. Parekh, A.A. Shadrin, P. Jaholkowski, L.A.R. Ystaas, N. Parker, O.B. Smeland, E.P. Tissink, I.E. Sønderby, et al.

    Early-childhood temperament is associated with mental health outcomes decades later. Temperament reflects early-emerging individual differences in emotional and behavioral tendencies. These differences are relatively stable across development and shaped by both genetic and environmental influences. However, the consequences of departures from expected developmental trajectories remain largely unexplored. Using data from more than 50,000 children in the Norwegian Mother, Father and Child Cohort Study, we modeled longitudinal temperament trajectories at 1.5, 3, and 5 years of age and quantified deviations from expected development. Multivariate pattern analysis revealed latent dimensions linking these deviations to clinical diagnoses, with ADHD as the most prominent outcome. Time-to-event analysis showed that these dimensions were associated with a higher hazard of ADHD diagnosis across childhood and adolescence. Finally, genetic analyses identified loci jointly associated with temperament trajectories and ADHD, revealing age-dependent genetic effects. Together, these findings show that deviations from temperament trajectories in early childhood capture transdiagnostic vulnerability across development. Early temperament monitoring may thus serve as an indicator of later mental health risk.

  • Open Access

    The genetic architecture of human cerebellar morphology supports a key role for the cerebellum in human evolution and psychopathology

    by Torgeir Moberget, Dennis van der Meer, Shahram Bahrami, Daniel Roelfs, Oleksandr Frei, Tobias Kaufmann, Sara Fernandez-Cabello, Milin Kim, Thomas Wolfers, Joern Diedrichsen, et al.

    The functional domain of the cerebellum has expanded beyond motor control to also include cognitive and affective functions. In line with this notion, cerebellar volume has increased over recent primate evolution, and cerebellar alterations have been linked to heritable mental disorders. To map the genetic architecture of human cerebellar morphology, we here studied a large imaging genetics sample from the UK Biobank (n discovery = 27,302; n replication: 11,264) with state-of-the art neuroimaging and biostatistics tools. Multivariate GWAS on regional cerebellar MRI features yielded 351 significant genetic loci (226 novel, 94% replicated). Lead SNPs showed positive enrichment for relatively recent genetic mutations over the last 20-40k years (i.e., overlapping the Upper Paleolithic, a period characterized by rapid cultural evolution), while gene level analyses revealed enrichment for human-specific evolution over the last ∼6-8 million years. Finally, we observed genetic overlap with major mental disorders, supporting cerebellar involvement in psychopathology.


  • Open Access

    Novel Genomic Risk Loci shared between Juvenile Idiopathic Arthritis and other HLA-associated Autoimmune Diseases

    by Hamid Khoshfekr Rudsari, Piotr Jaholkowski, Srijana Bastakoti, Vera Fominykh, Kristine Løkås Haftorn, Alexey A. Shadrin, Benedicte A. Lie, Ole A. Andreassen, Helga Sanner

    Objectives: To investigate genetic architecture and identify novel risk loci shared between juvenile idiopathic arthritis (JIA) and other human leukocyte antigen (HLA)-associated autoimmune diseases (AIDs) by leveraging genome-wide association studies (GWAS) data. Methods: We analyzed GWAS summary statistics from over two million participants (123,997 cases and 1,843,249 controls) of European ancestry across multiple AIDs including JIA, autoimmune thyroid disease (AITD), celiac disease, inflammatory bowel disease (IBD), multiple sclerosis (MS), psoriasis (Ps), rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and type 1 diabetes (T1D). The conjunctional false discovery rate (conjFDR) method was employed to identify shared genetic loci, followed by functional annotation and pathway analysis. Results: We identified 46 novel loci shared between JIA and various AIDs: 17 with AITD, 16 with RA, 13 with IBD, five each with MS and Ps, four with SLE, and seven with T1D. Notable shared risk genes included BACH2, UBASH3A, IRF4, IL12A-AS1, ETS1, PSMD14, FOXK1, NEK6, SP140, TNIP1, VAV3, CYP20A1, DNMT3A, LAX1, CASC15, ZC3H12C, KALRN, TBC1D1, PIK3CB, ANXA6 , and HIF1A . Functional annotation revealed 170 nonsynonymous exonic variants and 478 potentially deleterious variants (CADD score > 12.37). Gene Ontology analysis consistently highlighted enrichment of T cell-related processes and immune system regulation pathways. Conclusion: This study expands the understanding of genetic architecture in JIA by identifying novel risk loci shared with other AIDs. The extensive genetic overlap and shared biological pathways, particularly in T cell-mediated immunity, suggest common pathogenic mechanisms and potential therapeutic targets across multiple autoimmune conditions.

  • PrecInNor: An Indo-Norway collaborative programme for precision psychiatry training

    by Satish Suhas, Pravesh Parekh, Vanteemar S Sreeraj, Biju Viswanath, Srdjan Djurovic, Oleksandr Frei, Alexey A. Shadrin, Olav Bjerkehagen Smeland, Torill Ueland, Christine Lycke Brandt, et al.

  • Open Access

    Prostate cancer risk prediction using polygenic hazard scores in Norwegian populations

    by Andrew H. Morris, Bayram C. Akdeniz, Sigve Nakken, Alexey Shadrin, Anders M. Dale, Ole A. Andreassen, Eivind Hovig, Tyler M. Seibert, Oleksandr Frei

    More accurate risk prediction is needed for prostate cancer (PCa) to identify individuals at greatest risk of early-onset and clinically significant disease. Current screening paradigms, such as prostate-specific antigen screening, pose risks due to over-diagnosis and over-treatment of indolent disease. Polygenic hazard scores (PHS) can predict age-at-diagnosis of PCa and are being tested in prospective clinical screening trials. We assessed the performance of the latest PHS model for PCa (PHS601) in two Norwegian population-based cohort studies (N = 14,688 and N = 2,850) for predicting age-at-diagnosis of PCa and aggressive PCa. In a subset with whole-genome sequencing (N = 503), we directly compared PHS601-based stratification with screening for rare pathogenic variants. PHS601 effectively stratified participants by risk in both cohorts for both PCa (HR 80/20 = 5.74, 95% CI [5.06, 6.45] and 7.79 95% CI [5.70, 10.59]) and aggressive PCa (HR 80/20 = 4.60, 95% CI [3.19, 6.45] and 3.14 95% CI [1.49, 6.63]). Among individuals with whole-genome sequencing, the top 1.8% of PHS values conferred 8.8-fold higher risk than the median (HR = 8.78 [5.00, 14.40]), exceeding the risk associated with HOXB13 pathogenic variants (HR = 3.77 [1.75, 8.11]; 1.8% carrier frequency). This study provides the first external validation of PHS601 in independent Norwegian population-based cohorts and, within a WGS subset, a direct comparison with rare variant screening, supporting context-specific use of genotyping-based risk stratification in population screening.

  • Open Access

    Shared genetic architecture between anorexia nervosa and metabolomic biomarkers suggest underlying causal pathways

    by Carolina Makowski, Alexey Shadrin, Anders Dale, Ole Andreassen, Dennis Van Der Meer

    Background: Anorexia Nervosa (AN) has a high mortality rate and often a chronic illness course, but lacks effective treatments. AN is heritable and shares genetic architecture with cardiometabolic traits, while the relationship to metabolomic markers is unknown. Methods: We examined shared genetic architecture between AN and 249 metabolomic biomarkers, and compared profiles with related mental health, anthropometric and cardiometabolic traits. Genetic and biological overlap was assessed with global genetic correlations, conjunctional false discovery rate, bivariate Gaussian mixture modeling, and gene set enrichment analysis across body tissues. We also explored causal relationships between AN, body mass index (BMI), and metabolomic biomarkers. Results: Significant genetic correlations were found between AN and 142 metabolomic biomarkers, which were opposite in direction to cardiometabolic traits such as BMI and type 2 diabetes (r s <-0.94), and stronger than correlations with anxiety. Shared variants between AN and metabolomic biomarkers, particularly lipid-based metabolites, exhibited a mixture of positive and negative effects. These were mapped to genes involved in lipid-related cell signals, developmental growth, and inflammation, and were widely expressed in the brain, most internal organs and female reproductive organs. Causal bidirectional influences between AN and metabolomic biomarkers were found to act through their respective influence on BMI. Conclusions: Strong associations between AN and metabolomic markers, opposite in direction to anthropometric and cardiometabolic traits, are driven by developmental and lipid-based biological processes, with a potential mediating role of BMI. The findings offer a novel perspective on the mechanisms of AN and suggest opportunities for targeting specific metabolomic biomarkers in weight restoration approaches.


  • Open Access

    Distinct patterns of genetic overlap among multimorbidities revealed with trivariate MiXeR

    by Alexey A. Shadrin, Guy Hindley, Espen Hagen, Nadine Parker, Markos Tesfaye, Piotr Jaholkowski, Zillur Rahman, Gleda Kutrolli, Vera Fominykh, Srdjan Djurovic, et al.

    Background: Multimorbidities are a global health challenge. Accumulating evidence indicates that overlapping genetic architectures underlie comorbid complex human traits and disorders. This can be quantified for a pair of phenotypes using various techniques. Still, the pattern of genetic overlap between three distinct complex phenotypes, which is important for understanding multimorbidities, has not been possible to quantify. Methods: Here, we present and validate the novel trivariate MiXeR tool, which disentangles the pattern of genetic overlap between three complex phenotypes using summary statistics from genome-wide association studies. Our simulations show that trivariate MiXeR can reliably reconstruct different patterns of genetic overlap and estimate the proportions of genetic overlap between three phenotypes. Results: We found substantial genetic overlap between gastro-intestinal and brain diseases supporting a genetic basis of the gut-brain axis—the pattern consistent with pairwise analysis. However, the pattern of genetic overlap between three diverse cardiometabolic and renal health indicators and three immune-linked disorders revealed a much larger genomic component shared between all phenotypes than expected from separate pairwise analyses. This suggests the existence of core pathways underlying distinct but related chronic conditions. Conclusions: Overall, trivariate MiXeR offers a novel and efficient tool for investigating patterns of genetic overlap among three complex phenotypes. This contributes to a better understanding of genetic relationships between complex traits and disorders, potentially providing new insights into the mechanisms underlying common multimorbidities. Trivariate MiXeR is freely available at https://github.com/precimed/mix3r.


  • Open Access

    Distinct metabolic signatures of Alzheimer’s and Parkinson’s disease revealed through genetic overlap with metabolic markers

    by Sara Elizabeth Stinson, Alexey A. Shadrin, Zilur Rahman, Linn Rødevand, Iris J. Broce, Karin Persson, Geir Selbæk, Hreinn Stefansson, Jan Haavik, Nadine Parker, et al.

    Metabolic dysfunction is increasingly implicated in neurodegenerative diseases, yet the genetic architecture linking metabolic markers with Alzheimer’s disease (AD) and Parkinson’s disease (PD) remains unclear. We systematically analysed phenotypic and genetic relationships between 249 circulating metabolites with AD and PD, comparing patterns to body mass index (BMI), type 2 diabetes (T2D), coronary artery disease (CAD) and stroke. Using linkage disequilibrium score regression and bivariate Gaussian mixture modeling, we identified distinct genetic overlap. AD correlated positively with cardiometabolic traits (BMI, r s =0.11; T2D, r s =0.23; CAD, r s =0.22; stroke, r s =0.18), whereas PD showed opposing patterns (AD–PD r s =−0.36). Mendelian randomization identified bi-directional causal effects of lipid measures on AD and divergent effects of glutamine on AD and PD. Conjunctional FDR analyses mapped 1,377 shared genes, implicating lipid metabolism in AD and synaptic processes in PD. These findings disentangle disease-specific pathways and inform therapeutic strategies targeting metabolic health.